Literature DB >> 19521697

A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.

Samia Rourou1, Arno van der Ark, Samy Majoul, Khaled Trabelsi, Tiny van der Velden, Héla Kallel.   

Abstract

Vero cells growth and rabies production in IPT-AF medium, a property animal-component-free medium are described in this work. Kinetics of cell growth and rabies virus (strain LP 2061) production were first conducted in spinner flasks. Over eight independent experiments, Vero cell growth in IPT-AF medium, on 2 g/l Cytodex 1 was consistent. An average Cd (cell division number) of 3.3+/-0.4 and a specific growth rate micro of 0.017+/-0.006 h(-1) were achieved. Such performances were comparable to those obtained in serum-containing medium (MEM+10% FCS). Rabies virus production on Vero cells in IPT-AF medium was also optimised in spinner flasks. The effects of multiplicity of infection (MOI), regulation of glucose level at 1 g/l and cell washing step, were investigated. The highest virus titer was achieved when the cells were infected at an MOI of 0.1; this level was equal to 10(7) FFU/ml. The step of medium exchange before cell infection can be omitted; nevertheless in this case glucose level should be maintained at 1 g/l to avoid a decrease of specific virus productivity. Process optimisation in a 2-l stirred bioreactor pointed out that the aeration mode was the prominent parameter that affected cell growth in IPT-AF medium and on Cytodex 1 microcarriers. An acceptable level of cell density (cell density level of 1.5x10(6) cells/ml) was achieved when cells were grown in batch mode and using headspace aeration. Nevertheless, this aeration mode is not optimal for large-scale culture. The addition of Pluronic F68 at 0.1% at 24 h post inoculation as well as the switch from surface aeration mode to the sparged mode, 2 days after the start of the culture, had markedly improved cell growth performance. A cell density level of 5.5x10(6) cells/ml was reached when cells were grown in a 2-l bioreactor, on 3 g/l Cytodex 1 in IPT-AF medium and using the recirculation culture mode. Cell infection at an MOI of 0.1 and using perfused culture, resulted in a maximal virus titer of 3.5x10(7) FFU/ml. The activity of the pooled inactivated rabies virus harvests showed a protective activity that meets WHO requirements.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521697     DOI: 10.1007/s00253-009-2064-y

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  6 in total

Review 1.  Progress and challenges in viral vector manufacturing.

Authors:  Johannes C M van der Loo; J Fraser Wright
Journal:  Hum Mol Genet       Date:  2015-10-30       Impact factor: 6.150

2.  Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach.

Authors:  Jianqi Nie; Yang Sun; Fei Han; Yankun Yang; Xiuxia Liu; Chunli Liu; Ye Li; Zhonghu Bai
Journal:  Cytotechnology       Date:  2020-02-21       Impact factor: 2.058

3.  Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.

Authors:  Allen Chen; Swan Li Poh; Christian Dietzsch; Elisabeth Roethl; Mylene L Yan; Say Kong Ng
Journal:  BMC Biotechnol       Date:  2011-08-11       Impact factor: 2.563

4.  Isolation of active peptides from plant hydrolysates that promote Vero cells growth in stirred cultures.

Authors:  Samia Rourou; Rym Hssiki; Héla Kallel
Journal:  BMC Proc       Date:  2011-11-22

5.  Evaluation of novel disposable bioreactors on pandemic influenza virus production.

Authors:  Chia-Chun Lai; Tsai-Chuan Weng; Yu-Fen Tseng; Jen-Ron Chiang; Min-Shi Lee; Alan Yung-Chih Hu
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

6.  Application of a real-time cell analysis system in the process development and quantification of Rift Valley fever virus clone 13.

Authors:  Boitumelo Moetlhoa; Leeann Naicker; Rose Hayeshi; Anne Grobler; Nobalanda B Mokoena; Crispen Mawadza
Journal:  Access Microbiol       Date:  2020-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.